Genetic variation in microRNA networks: the implications for cancer research BM Ryan, AI Robles, CC Harris Nature reviews cancer 10 (6), 389-402, 2010 | 1467 | 2010 |
Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning QH Ye, LX Qin, M Forgues, P He, JW Kim, AC Peng, R Simon, Y Li, ... Nature medicine 9 (4), 416-423, 2003 | 1087 | 2003 |
Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song, C Huang, J Li, X Dong, ... Cell 179 (2), 561-577. e22, 2019 | 776 | 2019 |
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 484 | 2020 |
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis SP Hussain, P Amstad, P He, A Robles, S Lupold, I Kaneko, M Ichimiya, ... Cancer research 64 (7), 2350-2356, 2004 | 473 | 2004 |
Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 471 | 2019 |
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246 T Cooks, IS Pateras, LM Jenkins, KM Patel, AI Robles, J Morris, ... Nature communications 9 (1), 771, 2018 | 443 | 2018 |
Induction of cyclin D1 overexpression by activated ras. J Filmus, AI Robles, W Shi, MJ Wong, LL Colombo, CJ Conti Oncogene 9 (12), 3627-3633, 1994 | 423 | 1994 |
Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 413 | 2021 |
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models E Caldas-Lopes, L Cerchietti, JH Ahn, CC Clement, AI Robles, A Rodina, ... Proceedings of the National Academy of Sciences 106 (20), 8368-8373, 2009 | 371 | 2009 |
Clinical outcomes and correlates of TP53 mutations and cancer AI Robles, CC Harris Cold Spring Harbor perspectives in biology 2 (3), a001016, 2010 | 350 | 2010 |
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo AI Robles, ML Rodriguez-Puebla, AB Glick, C Trempus, L Hansen, ... Genes & development 12 (16), 2469-2474, 1998 | 347 | 1998 |
Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 342 | 2020 |
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 333 | 2020 |
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis AI Robles, NA Bemmels, AB Foraker, CC Harris Cancer research 61 (18), 6660-6664, 2001 | 312 | 2001 |
Interaction between the microbiome and TP53 in human lung cancer KL Greathouse, JR White, AJ Vargas, VV Bliskovsky, JA Beck, ... Genome biology 19, 1-16, 2018 | 308 | 2018 |
Proteogenomic characterization of pancreatic ductal adenocarcinoma L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ... Cell 184 (19), 5031-5052. e26, 2021 | 295 | 2021 |
Whole-exome sequencing analyses of inflammatory bowel Disease− Associated colorectal cancers AI Robles, G Traverso, M Zhang, NJ Roberts, MA Khan, C Joseph, ... Gastroenterology 150 (4), 931-943, 2016 | 263 | 2016 |
Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression YJ Chen, TI Roumeliotis, YH Chang, CT Chen, CL Han, MH Lin, ... Cell 182 (1), 226-244. e17, 2020 | 234 | 2020 |
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 232 | 2021 |